1. Home
  2. LEXX vs WETH Comparison

LEXX vs WETH Comparison

Compare LEXX & WETH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • WETH
  • Stock Information
  • Founded
  • LEXX 2004
  • WETH 1992
  • Country
  • LEXX Canada
  • WETH China
  • Employees
  • LEXX N/A
  • WETH N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • WETH
  • Sector
  • LEXX Health Care
  • WETH
  • Exchange
  • LEXX Nasdaq
  • WETH Nasdaq
  • Market Cap
  • LEXX 22.7M
  • WETH 26.1M
  • IPO Year
  • LEXX N/A
  • WETH N/A
  • Fundamental
  • Price
  • LEXX $1.13
  • WETH $2.06
  • Analyst Decision
  • LEXX Strong Buy
  • WETH
  • Analyst Count
  • LEXX 1
  • WETH 0
  • Target Price
  • LEXX $4.00
  • WETH N/A
  • AVG Volume (30 Days)
  • LEXX 212.4K
  • WETH 306.3K
  • Earning Date
  • LEXX 01-09-2026
  • WETH 11-12-2025
  • Dividend Yield
  • LEXX N/A
  • WETH N/A
  • EPS Growth
  • LEXX N/A
  • WETH 81.55
  • EPS
  • LEXX N/A
  • WETH 0.62
  • Revenue
  • LEXX $615,923.00
  • WETH $43,519,385.00
  • Revenue This Year
  • LEXX $46.98
  • WETH N/A
  • Revenue Next Year
  • LEXX $17.26
  • WETH N/A
  • P/E Ratio
  • LEXX N/A
  • WETH $3.22
  • Revenue Growth
  • LEXX 49.85
  • WETH 6.08
  • 52 Week Low
  • LEXX $0.77
  • WETH $0.76
  • 52 Week High
  • LEXX $2.85
  • WETH $3.68
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 57.12
  • WETH 46.86
  • Support Level
  • LEXX $1.00
  • WETH $1.87
  • Resistance Level
  • LEXX $1.19
  • WETH $2.20
  • Average True Range (ATR)
  • LEXX 0.08
  • WETH 0.27
  • MACD
  • LEXX -0.00
  • WETH -0.09
  • Stochastic Oscillator
  • LEXX 66.25
  • WETH 19.32

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About WETH Wetouch Technology Inc.

Wetouch Technology Inc is a touch panel supplier focused on R&D, production, and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for the automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots, and charging stations. The company sells touchscreen products both domestically in China and internationally. The company generates the majority of its revenue from the PRC, followed by the Republic of China and Korea.

Share on Social Networks: